Anika Therapeutics ANIK
NASDAQ ANIK
$14.14 +0.19 (+1.36%)
As of: Nov 12, 2026 · 1:10 PM EST

Anika Therapeutics (ANIK) Cost of Revenue (2009 - 2026)

Updated

Anika Therapeutics' Cost of Revenue came in at $11.37 million for Q2 2026, down 18.0% from $13.86 million a year earlier but up 7.1% from the prior quarter.

Analysis

Anika Therapeutics (ANIK) Cost of Revenue (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Anika Therapeutics reported Cost of Revenue of $45.65 million, down 6.8% year-over-year; for FY2025, it was $49.01 million, up 11.6% from FY2024.

  • Cost of Revenue carries a five-year compound annual growth rate of -4.4% (FY2020 to FY2025).
  • Going back by year, Cost of Revenue was $43.91 million in FY2024 (+14.8%), $38.26 million in FY2023 (-5.8%), $40.61 million in FY2022 (-37.4%) and $64.85 million in FY2021 (+5.6%).
  • The five-year range for quarterly Cost of Revenue is -$8.67 million (Q4 2023) to $17.69 million (Q4 2021).
  • Year-over-year, Cost of Revenue has declined for three consecutive quarters, with an average decline of 1.3% over the last seven quarters.
  • The fastest year-over-year change in Cost of Revenue over five years came in Q2 2025 (growth of 35.4%), and the weakest in Q3 2024 (a decline of 38.6%).
  • Business Quant data shows ANIK's Cost of Revenue at $10.62 million (Q1 2026), $11.44 million (Q4 2025) and $12.23 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 7.01 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 5.63 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 2.72 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 964.40 Mn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 3.42 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 2.27 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 1.71 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 369.20 Mn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 5.93 Bn
10 Anika Therapeutics 180.43 Mn -104.21 Mn 18.84 Mn 11.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11.76 Mn
Jun 30, 2026 11.37 Mn
Mar 31, 2026 10.62 Mn
Dec 31, 2025 11.44 Mn
Sep 30, 2025 12.23 Mn
Jun 30, 2025 13.86 Mn
Mar 31, 2025 11.49 Mn
Dec 31, 2024 13.48 Mn
Sep 30, 2024 10.15 Mn
Jun 30, 2024 10.24 Mn
Mar 31, 2024 10.05 Mn
Dec 31, 2023 -8.67 Mn
Sep 30, 2023 16.52 Mn
Jun 30, 2023 15.33 Mn
Mar 31, 2023 15.08 Mn
Dec 31, 2022 -6.56 Mn
Sep 30, 2022 17.49 Mn
Jun 30, 2022 14.80 Mn
Mar 31, 2022 14.89 Mn
Dec 31, 2021 17.69 Mn
API Access

Anika Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ANIK&period=max&api_key=YOUR_API_KEY